XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.21.2

Earn-Out Milestone Liability | 9 Months Ended
--- | ---
Sep. 30, 2021
Earn-out Milestone Liability |
Earn-Out Milestone Liability | Note 14. Earn-Out Milestone Liability On March 28, 2019, the Company and EGWU, Inc. entered into an amendment to its purchase agreement (“Amended Asset Purchase Agreement”), whereby payment of the earnout milestone liability related to the Ovarian Cancer Indication of $12.4 million had been modified. The Company has the option to make the payment as follows:
a) | $7.0 million in cash within 10 business days of achieving the milestone; or
b) | $12.4 million in cash, common stock of the Company, or a combination of either, within one year of achieving the milestone.
As of September 30, 2021, June 30, 2021, and December 31, 2020, the Company calculated the fair value of the earn-out milestone liability at $7.3 million, $7.1 million and $7.0 million, respectively, and recognized a non-cash charge of $0.3 million and for each of the three-months and nine months ended September 30, 2021. In assessing the earnout milestone liability at September 30, 2021 and June 30, 2021, the Company determined the fair value of each of the two payment options per the Amended Asset Purchase Agreement and weighted them at 50% and 50% probability for the $7.0 million and the $12.4 million payments, respectively. As of September 30, 2020, June 30, 2020 and December 31, 2019, the Company calculated the fair value of the earn-out milestone liability at $7.1 million, $6.0 million, and $5.7 million, respectively, and recognized a non-cash charge of $1.1 and $1.4 million for the three-month and nine-month periods ended September 30, 2020, respectively. In assessing the earnout milestone liability at September 30, 2020, the Company fair valued each of the two payment options per the Amended Asset Purchase Agreement and weighted them at 50% and 50% probability for the $7.0 million and the $12.4 million payments, respectively, and at June 30, 2020, the Company determined the fair value of each of the two payment options per the Amended Asset Purchase Agreement and weighted them at 80% and 20% probability for the $7.0 million and the $12.4 million payments, respectively. The following is a summary of the changes in the earn-out milestone liability for the nine-month period ended September 30, 2021: Schedule of Changes in Earn-out Milestone Liability
Balance at January 1, 2021 |  | $ | (7,018,000 | )
Non-cash loss from the change in fair value |  |  | (327,000 | )
Balance at September 30, 2021 |  | $ | (7,345,000 | )
The following is a schedule of the Company’s risk-adjustment assessment of each milestone: Schedule of Risk Adjustment Assessment
Date |  | Risk-adjustment Assessment of Achieving Each Milestone |  |  | Discount Rate |  |  | Estimated Time to Achieve
September 30, 2021 |  |  | 80 | % |  |  | 6.54% to 6.60 | % |  | 0.29 to 1.29 years
June 30, 2021 |  |  | 80 | % |  |  | 9 | % |  | 0.42 to 1.42 years
December 31, 2020 |  |  | 80 | % |  |  | 9 | % |  | 0.54 to 1.54 years
September 30, 2020 |  |  | 80 | % |  |  | 9 | % |  | 0.38 to 1.38 years
June 30, 2020 |  |  | 80 | % |  |  | 9 | % |  | 0.54 to 1.54 years
December 31, 2019 |  |  | 80 | % |  |  | 9 | % |  | 1.12 to 2.12 years

X
- References No definition available. + Details
Name: | CLSN_DisclosureEarnoutMilestoneLiabilityAbstract
Namespace Prefix: | CLSN_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnout Milestone Liability Disclosure [Text Block] + References No definition available. + Details
Name: | CLSN_EarnoutMilestoneLiabilityDisclosureTextBlock
Namespace Prefix: | CLSN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration